Related Experiment Video
Updated: May 5, 2026
Modeling Human Cerebellar Development In Vitro in 2D Structure
Published on: September 16, 2022
Morphological analysis of embryonic cerebellar grafts in SCA2 mice
Zdenka Purkartova1, Jan Tuma2, Martin Pesta3
1Department of Pathophysiology, Faculty of Medicine in Pilsen, Charles University, Lidicka 1, Pilsen 301 66, Czech Republic.
Abstract:
SCA2 transgenic mice are thought to be a useful model of human spinocerebellar ataxia type 2. There is no effective therapy for cerebellar degenerative disorders, therefore neurotransplantation could offer hope. The aim of this work was to assess the survival and morphology of embryonic cerebellar grafts transplanted into the cerebellum of adult SCA2 mice. Four month-old homozygous SCA2 and negative control mice were treated with bilateral intracerebellar injections of an enhanced green fluorescent protein-positive embryonic cerebellar cell suspension. Graft survival and morphology were examined three months later. Graft-derived Purkinje cells and the presence of astrocytes in the graft were detected immunohistochemically. Nissl and hematoxylin-eosin techniques were used to visualize the histological structure of the graft and surrounding host tissue. Grafts survived in all experimental mice; no differences in graft structure, between SCA2 homozygous and negative mice, were found. The grafts contained numerous Purkinje cells but long distance graft-to-host axonal connections to the deep cerebellar nuclei were rarely seen. Relatively few astrocytes were found in the center of the graft. No signs of inflammation or tissue destruction were seen in the area around the grafts. Despite good graft survival and the presence of graft-derived Purkinje cells, the structure of the graft did not seem to promise any significant specific functional effects. We have shown that the graft is available for long-term experiments. Nevertheless, it would be beneficial to search for ways of enhancement of connections between the graft and host.
Insights
Embryonic cerebellar grafts survived well in SCA2 mice, a model for spinocerebellar ataxia type 2. However, limited connections between graft and host suggest limited functional recovery, necessitating further research.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Genetics
Background:
- Spinocerebellar ataxia type 2 (SCA2) is a progressive neurodegenerative disorder with no effective treatments.
- Neurotransplantation of embryonic cerebellar grafts offers a potential therapeutic strategy for cerebellar degenerative disorders.
- SCA2 transgenic mice serve as a relevant model for studying human SCA2.
Purpose of the Study:
- To evaluate the survival and morphology of embryonic cerebellar grafts in adult SCA2 transgenic mice.
- To assess the integration and cellular composition of these grafts within the host cerebellum.
- To determine the potential for functional recovery based on graft-host connectivity.
Main Methods:
- Bilateral intracerebellar injections of enhanced green fluorescent protein-positive embryonic cerebellar cell suspension into adult SCA2 homozygous and control mice.
- Immunohistochemical analysis to detect graft-derived Purkinje cells and astrocytes.
- Histological examination using Nissl and hematoxylin-eosin staining to assess graft and host tissue structure.
Main Results:
- Embryonic cerebellar grafts demonstrated good survival in all experimental mice, with no significant structural differences between SCA2 and control groups.
- Grafts contained numerous Purkinje cells, but long-distance axonal connections to host deep cerebellar nuclei were infrequent.
- A low density of astrocytes was observed in the graft center, with no signs of inflammation or host tissue destruction around the grafts.
Conclusions:
- Embryonic cerebellar grafts survive long-term in SCA2 mice, providing a viable platform for further research.
- The presence of graft-derived Purkinje cells is confirmed, but limited graft-host connectivity may restrict functional restoration.
- Future strategies should focus on enhancing axonal connections between the graft and host cerebellum to improve therapeutic potential.
